419 related articles for article (PubMed ID: 11511026)
41. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
Maspero JF; Nolte H; Chérrez-Ojeda I;
J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
[TBL] [Abstract][Full Text] [Related]
42. Mometasone furoate dry powder inhaler for the treatment of asthma.
Fausnight TB; Craig TJ
Expert Opin Pharmacother; 2011 Dec; 12(17):2707-12. PubMed ID: 22049912
[TBL] [Abstract][Full Text] [Related]
43. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
Weinstein SF; Corren J; Murphy K; Nolte H; White M;
Allergy Asthma Proc; 2010; 31(4):280-9. PubMed ID: 20687982
[TBL] [Abstract][Full Text] [Related]
44. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.
Nathan RA; Nolte H; Pearlman DS;
Allergy Asthma Proc; 2010; 31(4):269-79. PubMed ID: 20678306
[TBL] [Abstract][Full Text] [Related]
45. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
46. Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids.
Frampton JE
Drugs; 2012 Jun; 72(9):1229-41. PubMed ID: 22568730
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
48. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma.
Friedman HS; Navaratnam P; McLaughlin J
J Asthma; 2010 Nov; 47(9):994-1000. PubMed ID: 20831468
[TBL] [Abstract][Full Text] [Related]
49. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.
Karpel J; D'urzo A; Lockey RF
J Asthma; 2008 Nov; 45(9):747-53. PubMed ID: 18972289
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
51. Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents.
Anolik R; Pearlman D; Teper A; Gates D
Allergy Asthma Proc; 2009; 30(4):406-12. PubMed ID: 19467175
[TBL] [Abstract][Full Text] [Related]
52. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
53. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.
Stjärne P; Mösges R; Jorissen M; Passàli D; Bellussi L; Staudinger H; Danzig M
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):179-85. PubMed ID: 16490876
[TBL] [Abstract][Full Text] [Related]
54. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
55. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.
Hvizdos KM; Jarvis B
Drugs; 2000 Nov; 60(5):1141-78. PubMed ID: 11129126
[TBL] [Abstract][Full Text] [Related]
56. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group.
Meltzer EO; Charous BL; Busse WW; Zinreich SJ; Lorber RR; Danzig MR
J Allergy Clin Immunol; 2000 Oct; 106(4):630-7. PubMed ID: 11031332
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.
Pereira CA; Vianna FF; Cukier A; Stelmach R; Oliveira JC; Carvalho EV; Gomes EP; Mayo SV; Chibante AM; Domingues CP
J Bras Pneumol; 2010; 36(4):410-6. PubMed ID: 20835586
[TBL] [Abstract][Full Text] [Related]
58. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
Holgate ST; Arshad H; Stryszak P; Harrison JE
J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
[TBL] [Abstract][Full Text] [Related]
59. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
Martinez FD; Chinchilli VM; Morgan WJ; Boehmer SJ; Lemanske RF; Mauger DT; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bade E; Covar RA; Friedman NJ; Guilbert TW; Heidarian-Raissy H; Kelly HW; Malka-Rais J; Mellon MH; Sorkness CA; Taussig L
Lancet; 2011 Feb; 377(9766):650-7. PubMed ID: 21324520
[TBL] [Abstract][Full Text] [Related]
60. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.
Calverley PM; Rennard S; Nelson HS; Karpel JP; Abbate EH; Stryszak P; Staudinger H
Respir Res; 2008 Nov; 9(1):73. PubMed ID: 19014549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
